Tim Hawkins Appointed CEO of Rephine to Drive Global Growth and Elevate GMP Audit and Consulting Service
Position
Chief Executive Officer
Company
Rephine
Description
Rephine proudly announces the appointment of Tim Hawkins as its new Chief Executive Officer (CEO) to intensify its global expansion and strengthen its leadership in quality assurance and supply chain compliance for the pharmaceutical, biotech, and medical device sectors. Tim Hawkins brings over two decades of pharmaceutical and healthcare industry experience, particularly through his time at McKinsey, Elsevier, and most recently at BioPhorum, where he played a crucial role in driving the organisation’s growth as a global collaboration platform for biopharmaceutical leaders.
Quick answer
Tim Hawkins Appointed CEO of Rephine to Drive Global Growth and Elevate GMP Audit and Consulting Service (September 23, 2024). Rephine is based in Hertford, Hertfordshire, United Kingdom.
- Who is the new Chief Executive Officer at Rephine?
- Rephine named Tim Hawkins Chief Executive Officer, announced September 23, 2024.
- What did Rephine announce on September 23, 2024?
- Rephine proudly announces the appointment of Tim Hawkins as its new Chief Executive Officer (CEO) to intensify its global expansion and strengthen its leadership in quality assurance and supply chain compliance for the pharmaceutical, biotech, and medical device sectors. Tim Hawkins brings over two decades of pharmaceutical and healthcare industry experience, particularly through his time at McKinsey, Elsevier, and...
- What does Rephine do?
- Rephine is a respected life sciences QA and GxP compliance specialist, providing quality assurance (QA) and Good Manufacturing/Distribution Practice (GxP) compliance across pharmaceutical, biotech & medical device...
- Where is Rephine based?
- Rephine is based in Hertford, Hertfordshire, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Denbright Dental Labs (September 24, 2024), Century Therapeutics (September 27, 2024), CivicaScript (September 17, 2024) and RELJA Innovations (September 13, 2024) also announced leadership changes within 45 days of Rephine.
Source: Fundz verified event record.
Other recent leadership changes in Quality Assurance and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Denbright Dental Labs Appoints David Casper as Chief Executive Officer and Strengthens Management Team (September 24, 2024)
- Century Therapeutics appoints Morgan Conn as Chief Financial Officer and Chad Cowen as Chief Scientific Officer (September 27, 2024)
- CivicaScript Names Brent J. Eberle, R.Ph., M.B.A. as President, as Gina Guinasso, J.D. Leaves (September 17, 2024)
- RELJA Innovations appoints David Kelly as Chief Commercial Officer to drive commercialization of suite of bunion surgery products (September 13, 2024)
- Iridex Appoints Patrick Mercer as Chief Executive Officer and President, David Bruce Transitioning (October 3, 2024)
- Boston Scientific Appoints Dr. Angelo Auricchio as Chief Medical Officer of Rhythm Management Business in EMEA (September 11, 2024)
Who to call at Rephine, and when
A new leader at Rephine brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Rephine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rephine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rephine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rephine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rephine changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.